Kestutis Micke
Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Diseases | 1 | 2022 | 148 | 0.810 |
Why?
| Urinary Bladder | 1 | 2022 | 180 | 0.760 |
Why?
| Prenatal Care | 1 | 2023 | 252 | 0.750 |
Why?
| Fetus | 1 | 2023 | 690 | 0.660 |
Why?
| Bartter Syndrome | 1 | 2023 | 8 | 0.240 |
Why?
| Polyhydramnios | 1 | 2023 | 18 | 0.240 |
Why?
| Abortion, Spontaneous | 1 | 2023 | 94 | 0.230 |
Why?
| Duodenum | 1 | 2022 | 67 | 0.220 |
Why?
| Muscle, Smooth | 1 | 2022 | 157 | 0.210 |
Why?
| Workflow | 1 | 2023 | 148 | 0.210 |
Why?
| Genetic Counseling | 1 | 2021 | 66 | 0.200 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2023 | 189 | 0.190 |
Why?
| Actins | 1 | 2022 | 404 | 0.190 |
Why?
| Genetic Testing | 1 | 2023 | 389 | 0.190 |
Why?
| Premature Birth | 1 | 2023 | 284 | 0.180 |
Why?
| Prenatal Diagnosis | 1 | 2021 | 168 | 0.180 |
Why?
| Epilepsy | 1 | 2023 | 290 | 0.170 |
Why?
| Simeprevir | 1 | 2018 | 9 | 0.160 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 28 | 0.160 |
Why?
| Protease Inhibitors | 1 | 2018 | 102 | 0.150 |
Why?
| HIV Integrase Inhibitors | 1 | 2018 | 60 | 0.150 |
Why?
| Pregnancy | 3 | 2023 | 5690 | 0.140 |
Why?
| Female | 5 | 2023 | 61564 | 0.090 |
Why?
| Humans | 6 | 2023 | 118972 | 0.070 |
Why?
| Fetal Death | 1 | 2023 | 52 | 0.060 |
Why?
| Child | 1 | 2022 | 19129 | 0.060 |
Why?
| Glycosylation | 1 | 2023 | 129 | 0.060 |
Why?
| Siblings | 1 | 2023 | 235 | 0.050 |
Why?
| Antigens, Neoplasm | 1 | 2023 | 228 | 0.050 |
Why?
| Mutation, Missense | 1 | 2023 | 300 | 0.050 |
Why?
| Aneuploidy | 1 | 2021 | 88 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 394 | 0.050 |
Why?
| Oxazines | 1 | 2018 | 25 | 0.040 |
Why?
| Area Under Curve | 1 | 2018 | 296 | 0.040 |
Why?
| Pyridones | 1 | 2018 | 119 | 0.040 |
Why?
| Hepacivirus | 1 | 2018 | 230 | 0.030 |
Why?
| Piperazines | 1 | 2018 | 316 | 0.030 |
Why?
| Hepatitis C | 1 | 2018 | 217 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 965 | 0.030 |
Why?
| Infant, Newborn | 1 | 2023 | 5255 | 0.030 |
Why?
| HIV-1 | 1 | 2018 | 776 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4552 | 0.020 |
Why?
| Prospective Studies | 1 | 2018 | 6471 | 0.020 |
Why?
| United States | 1 | 2021 | 12555 | 0.020 |
Why?
| Male | 2 | 2023 | 57801 | 0.020 |
Why?
| Retrospective Studies | 1 | 2021 | 12978 | 0.020 |
Why?
| HIV Infections | 1 | 2018 | 2459 | 0.010 |
Why?
| Adult | 1 | 2018 | 31512 | 0.010 |
Why?
|
|
Micke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|